Brown, Rebecca C. http://orcid.org/0000-0002-8025-7847
Heines, Stefanie
Witt, Andreas
Braehler, Elmar
Fegert, Joerg M.
Harsch, Daniela
Plener, Paul L.
Article History
Received: 21 November 2017
Accepted: 21 May 2018
First Online: 8 June 2018
Ethics approval and consent to participate
: The study was conducted in accordance with the Declaration of Helsinki, and fulfilled the ethical guidelines of the International Code of Marketing and Social Research Practice of the International Chamber of Commerce and of the European Society of Opinion and Marketing Research. All participants (and if applicable their caregivers) gave informed written consent. The study was approved by the Ethics Committee of the Medical Department of the University of Leipzig.
: All authors declare to have no competing interests. JMF has received research funding from the EU, DFG (ExternalRef removed), BMG (Federal Ministry of Health), BMBF (Federal Ministry of Education and Research), BMFSFJ (Federal Ministry of Family, Senior Citizens, Women and Youth), German armed forces, several state ministries of social affairs, State Foundation Baden-Württemberg, Volkswagen Foundation, European Academy, Pontifical Gregorian University, RAZ, CJD, Caritas, Diocese of Rottenburg-Stuttgart. Moreover, he received travel grants, honoraria and sponsoring for conferences and medical educational purposes from DFG, AACAP, NIMH/NIH, EU, Pro Helvetia, Janssen-Cilag (J&J), Shire, several universities, professional associations, political foundations, and German federal and state ministries during the last five years. Every grant and every honorarium has to be declared to the law office of the University Hospital Ulm. Professor Fegert holds no stocks of pharmaceutical companies. PLP has received research funding from the German Federal Institute for Drugs and Medical Devices (BfARM), the German Federal Ministry of Education and Research (BMBF), VW-Foundation, Baden-Württemberg Stiftung, Lundbeck and Servier. He received a speaker’s honorarium from Shire. He is a member of the Editorial Board for BMC Psychiatry. Professor Plener holds no stocks of pharmaceutical companies.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.